Strides Shasun receives USFDA approval for Nystatin and Triamcinolone Acetonide Ointment

Strides Shasun's wholly owned subsidiary Strides Pharma Global Pte. Limited has received approval for Nystatin and Triamcinolone Acetonide Ointment USP, 0.1% from the United States Food & Drug Administration (USFDA).

January 31, 2018 / 10:38 IST

26 Aug, 2025 12:21

Volume

Todays L/H

Strides Shasun's wholly owned subsidiary Strides Pharma Global Pte. Limited has received approval for Nystatin and Triamcinolone Acetonide Ointment USP, 0.1% from the United States Food & Drug Administration (USFDA).

This is the first topical approval received from the new semi solids block at the flagship plant in Bangalore. Source : BSE

first published: Jan 31, 2018 10:38 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347